BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 36284286)

  • 1. Parathyroid carcinoma during pregnancy: a novel pathogenic CDC73 mutation - a case report.
    Dematapitiya C; Perera C; Pathmanathan S; Subasinghe V; Anandagoda G; Dissanayaka V; Wijenayake U; Dissanayake P; Gamage K; Wijewickrama P; Sumanatilleke M
    BMC Endocr Disord; 2022 Oct; 22(1):259. PubMed ID: 36284286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute presentation of a giant intrathyroidal parathyroid adenoma: a case report.
    Rutledge S; Harrison M; O'Connell M; O'Dwyer T; Byrne MM
    J Med Case Rep; 2016 Oct; 10(1):286. PubMed ID: 27756436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
    Diao Z; Zhang J; Zhao J; Sun W; Pu Z
    BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left parathyroid carcinoma with secondary hyperparathyroidism: a case report.
    Yokoyama K; Suganuma N; Rino Y
    BMC Endocr Disord; 2023 May; 23(1):108. PubMed ID: 37193977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
    Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
    Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal parathyroid hormone levels in a diabetic patient with parathyroid adenoma.
    Gulcelik NE; Bozkurt F; Tezel GG; Kaynaroglu V; Erbas T
    Endocrine; 2009 Apr; 35(2):147-50. PubMed ID: 19116787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normocalcemic primary hyperparathyroidism: long-term follow-up associated with multiple adenomas.
    Pimentel L; Portela S; Loureiro A; Bandeira F
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):583-6. PubMed ID: 25166050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Nine-year-old with parathyroid adenoma within the piriform sinus.
    Zenno A; Ramamoorthy B; Hammoud DA; Quezado M; Zeiger MA; Jha S
    Front Endocrinol (Lausanne); 2023; 14():1171052. PubMed ID: 37288292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
    Saponaro F; Pardi E; Mazoni L; Borsari S; Torregrossa L; Apicella M; Frustaci G; Materazzi G; Miccoli P; Basolo F; Marcocci C; Cetani F
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4565-e4579. PubMed ID: 34157106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid Cancer in the Pediatric Patient.
    Davidson JT; Lam CG; McGee RB; Bahrami A; Diaz-Thomas A
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):32-7. PubMed ID: 26650250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature.
    Serrano-Gonzalez M; Shay S; Austin J; Maceri DR; Pitukcheewanont P
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1005-12. PubMed ID: 27544721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachronous primary hyperparathyroidism due to a parathyroid adenoma and a subsequent carcinoma: report of a case.
    Ito Y; Iwase H; Tanaka H; Yuasa H; Kureyama Y; Yamashita H; Toyama T; Kimura M; Kobayashi S
    Surg Today; 2001; 31(10):895-8. PubMed ID: 11759885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical parathyroid adenoma: Severe manifestations in an adolescent girl.
    Boro H; Alam S; Kubihal V; Khatiwada S; Kubihal S; Agarwal S; Khadgawat R
    Pediatr Endocrinol Diabetes Metab; 2022; 28(1):91-100. PubMed ID: 35193332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
    Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
    Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.
    Gurrado A; Marzullo A; Lissidini G; Lippolis A; Rubini D; Lastilla G; Testini M
    World J Surg Oncol; 2008 Feb; 6():24. PubMed ID: 18291038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathyroidal parathyroid carcinoma as cause of hypercalcemia and pitfall of localization techniques: clinical and biologic features.
    Foppiani L; Del Monte P; Sartini G; Arlandini A; Quilici P; Bandelloni R; Marugo A; Bernasconi D
    Endocr Pract; 2007; 13(2):176-81. PubMed ID: 17490933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Primary Hyperparathyroidism Secondary to an Ectopic Mediastinal Adenoma in a Young Adult: A Case Report.
    Nievera KH; Alba R
    J ASEAN Fed Endocr Soc; 2023; 38(2):145-148. PubMed ID: 38045675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hypercalcaemia associated with two pathogenic variants in the
    Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
    Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary hyperparathyroidism after removal of a parathyroid adenoma.
    Jiménez-Montero JG; Lobo-Hernández E; Picado-Larios A; Molina MA
    Endocr Pract; 2002; 8(6):429-32. PubMed ID: 15260008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.